Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Skye Bioscience Inc
(OP:
SKYE
)
0.0398
+0.0011 (+2.84%)
Streaming Delayed Price
Updated: 3:58 PM EDT, May 27, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
649,109
Open
0.0361
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0387
Today's Range
0.0361 - 0.0440
52wk Range
0.0290 - 0.2589
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Skye Bioscience Signs Arrangement Agreement With Emerald Health Therapeutics, Here Are The Details
May 12, 2022
Skye Bioscience, Inc. (OTCQB: SKYE) and Emerald Health Therapeutics, Inc.
Via
Benzinga
Emerald Health Therapeutics Signs Arrangement Agreement with Skye Bioscience
May 12, 2022
Arrangement is expected to fund Skye's proprietary synthetic cannabinoid-derivative therapeutic initially targeting glaucoma for first Phase 2 clinical study planned to...
Via
Newsfile
Topics
Derivatives
Exposures
Derivatives
Performance
YTD
-27.64%
-27.64%
1 Month
+7.57%
+7.57%
3 Month
+9.64%
+9.64%
6 Month
-36.01%
-36.01%
1 Year
-63.49%
-63.49%
More News
Read More
Skye Bioscience Shares Up On Keeping Novotech As CRO For Phase 1 Trial Of THC Prodrug Candidate For Glaucoma
March 03, 2022
Via
Benzinga
Cannabis Movers & Shakers: Skye Bioscience, The Flowr Corp, Charlotte's Web, Rapid Dose Therapeutics
December 23, 2021
Via
Benzinga
These OTC Securities Had the Most Trading Activity in June
July 20, 2021
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Skye Bioscience Targets Unmet Needs Of Glaucoma Through Cannabinoids
April 08, 2021
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Watch CV Sciences & Lyphe Group On The Benzinga Cannabis Hour
July 08, 2021
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
CEO Presenting on the Emerging Growth Conference on June 9. Register here
June 07, 2021
Via
EIN Presswire
Keynotes, Educational Panels and 66 Companies to Present at the Planet MicroCap Showcase: VIRTUAL on April 20-22, 2021
April 19, 2021
From
Stock News Now
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.